Adaptimmune Therapeutics Plc Net Income
| ADAPDelisted Stock | USD 0.04 0 6.49% |
As of the 24th of February, Adaptimmune Therapeutics shows the risk adjusted performance of 0.0322, and Mean Deviation of 12.64. Adaptimmune Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Analyzing historical trends in various income statement and balance sheet accounts from Adaptimmune Therapeutics' financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Adaptimmune Therapeutics' valuation are summarized below:Adaptimmune Therapeutics Plc does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Adaptimmune |
Search Suggestions
| AD | Array Digital Infrastructure | Company |
| ADC-PA | Agree Realty | Company |
| ADX | Adams Diversified Equity | Fund |
| ADZ | Deutsche Bank | ETF |
| ADVN | NYSE Advancing Stocks | Index |
| ADX | ADX | Cryptocurrency |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Adaptimmune Therapeutics Plc reported net income of (70.81 Million). This is 120.75% lower than that of the Biotechnology sector and 201.1% lower than that of the Health Care industry. The net income for all United States stocks is 112.4% higher than that of the company.
Adaptimmune Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Adaptimmune Therapeutics' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Adaptimmune Therapeutics could also be used in its relative valuation, which is a method of valuing Adaptimmune Therapeutics by comparing valuation metrics of similar companies.Adaptimmune Therapeutics is currently under evaluation in net income category among its peers.
Adaptimmune Fundamentals
| Return On Equity | -13.41 | |||
| Return On Asset | -0.41 | |||
| Profit Margin | (2.61) % | |||
| Operating Margin | (2.21) % | |||
| Current Valuation | 31.98 M | |||
| Shares Outstanding | 265.05 M | |||
| Shares Owned By Insiders | 0.63 % | |||
| Shares Owned By Institutions | 31.23 % | |||
| Number Of Shares Shorted | 31.38 M | |||
| Price To Earning | (7.73) X | |||
| Price To Book | 2.68 X | |||
| Price To Sales | 0.22 X | |||
| Revenue | 178.03 M | |||
| Gross Profit | (63.61 M) | |||
| EBITDA | (52.66 M) | |||
| Net Income | (70.81 M) | |||
| Cash And Equivalents | 199.67 M | |||
| Cash Per Share | 1.22 X | |||
| Total Debt | 74.21 M | |||
| Debt To Equity | 0.20 % | |||
| Current Ratio | 4.00 X | |||
| Book Value Per Share | (0.27) X | |||
| Cash Flow From Operations | (73.21 M) | |||
| Short Ratio | 0.19 X | |||
| Earnings Per Share | (0.66) X | |||
| Price To Earnings To Growth | 0.11 X | |||
| Target Price | 0.68 | |||
| Number Of Employees | 506 | |||
| Beta | 2.49 | |||
| Market Capitalization | 14.55 M | |||
| Total Asset | 245.96 M | |||
| Retained Earnings | (1.09 B) | |||
| Working Capital | 123.64 M | |||
| Current Asset | 199.54 M | |||
| Current Liabilities | 22.66 M | |||
| Net Asset | 245.96 M |
About Adaptimmune Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Adaptimmune Therapeutics Plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Adaptimmune Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Adaptimmune Therapeutics Plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Adaptimmune Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Adaptimmune Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adaptimmune Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Adaptimmune Stock
| 0.53 | PPERY | Bank Mandiri Persero Normal Trading | PairCorr |
The ability to find closely correlated positions to Adaptimmune Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Adaptimmune Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Adaptimmune Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Adaptimmune Therapeutics Plc to buy it.
The correlation of Adaptimmune Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Adaptimmune Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Adaptimmune Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Adaptimmune Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Consideration for investing in Adaptimmune Stock
If you are still planning to invest in Adaptimmune Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Adaptimmune Therapeutics' history and understand the potential risks before investing.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |